Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $272.11 million. The enterprise value is $264.96 million.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSA has 118.82 million shares outstanding. The number of shares has decreased by -4.29% in one year.
| Current Share Class | 118.82M |
| Shares Outstanding | 118.82M |
| Shares Change (YoY) | -4.29% |
| Shares Change (QoQ) | +6.93% |
| Owned by Insiders (%) | 40.45% |
| Owned by Institutions (%) | 3.84% |
| Float | 63.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 29.58 |
| P/TBV Ratio | 29.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.72 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -232.31% and return on invested capital (ROIC) is -203.61%.
| Return on Equity (ROE) | -232.31% |
| Return on Assets (ROA) | -83.78% |
| Return on Invested Capital (ROIC) | -203.61% |
| Return on Capital Employed (ROCE) | -200.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.43M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.56M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +148.37% in the last 52 weeks. The beta is 0.24, so TLSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +148.37% |
| 50-Day Moving Average | 1.97 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 65.40 |
| Average Volume (20 Days) | 474,483 |
Short Selling Information
| Short Interest | 1.11M |
| Short Previous Month | 791,866 |
| Short % of Shares Out | 1.43% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.10 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -18.47M |
| Pretax Income | -14.40M |
| Net Income | -12.84M |
| EBITDA | -18.46M |
| EBIT | -18.47M |
| Earnings Per Share (EPS) | -$0.11 |
Full Income StatementBalance Sheet
The company has $7.25 million in cash and $107,000 in debt, giving a net cash position of $7.14 million or $0.06 per share.
| Cash & Cash Equivalents | 7.25M |
| Total Debt | 107,000 |
| Net Cash | 7.14M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 9.20M |
| Book Value Per Share | 0.08 |
| Working Capital | 5.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.75 million and capital expenditures -$11,000, giving a free cash flow of -$8.76 million.
| Operating Cash Flow | -8.75M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -8.76M |
| FCF Per Share | -$0.07 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
